How many employees does ellume limited have?
Note from Dr Sean Parsons – Managing Director & Founder. Despite advances in modern medicine, infectious diseases continue to pose a significant threat to humanity. Ellume was founded to address these problems through innovative approaches to diagnosis and treatment accessibility. During the 2009 swine flu pandemic I was working as a physician in a busy …
Who is the founder of ellume?
Ellume General Information Description. Operator of a health technology company based in East Brisbane, Queensland. The company develops a range of diagnostic tests for common infectious diseases and designs products which include home influenza tests, digital devices for clinics, and developing products for health crises tailored specifically for both the product user and the …
Is ellume Health publicly traded?
Oct 01, 2021 · Dr Sean Parsons. CEO and Founder. The Ellume COVID-19 Home Test has not been FDA cleared or approved. It has been authorized by the FDA under an emergency use authorization for non-prescription home use. The test has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens, and is only authorized for …
Where is ellume located?
May 10, 2021 · 20 July, 2021 Ellume Founder, CEO and Managing Director Dr Sean Parsons spoke with Peta Credlin on Sky News’ Credlin program about how Ellume’s range of COVID-19 tests are being sold in the U.S. to support efforts to combat the spread of COVID-19 within the community.
Did Ellume recall the COVID-19 home test?
Ellume is recalling certain lots of the COVID-19 Home Test because they have higher-than-acceptable false positive test results for SARS-CoV-2. The reliability of negative test results is not affected.
How accurate is the Ellume COVID-19 rapid test?
What if I can’t afford to pay for the at-home over-the-counter COVID-19 test(s) upfront?
Health plans and insurers are strongly incentivized to set up a network of convenient options across the country, such as pharmacies and retailers, where people will be able to order online or walk in and pick up at-home over-the-counter COVID-19 tests for free rather than going through the process of having to submit claims for reimbursement. Consumers can find out from their plan or insurer if it is providing direct coverage of over-the-counter COVID-19 tests through such a network of preferred pharmacies or retailers.
You can also access free testing in the community. A list of community-based testing sites can be found here. COVID-19 tests are also available without cost-sharing to covered individuals when administered by a health care provider like a nurse, doctor, or pharmacist, without limitation.
What is a self-home test for COVID-19?
Self-tests for COVID-19 give rapid results and can be taken anywhere, regardless of your vaccination status or whether or not you have symptoms. They detect current infection and are sometimes also called “home tests,” “at-home tests,” or “over-the-counter (OTC) tests.”
What is the accuracy of TaqPath COVID-19 kits?
Are molecular or rapid COVID-19 tests more accurate?
Molecular tests are generally more accurate and mostly processed in a laboratory, which takes longer; antigen tests—or “rapid tests”—are processed pretty much anywhere, including at home, in doctors’ offices, or in pharmacies.
Will I have to pay for my COVID-19 test up front?
The Biden-Harris Administration is strongly incentivizing health plans and insurers to set up a network of convenient locations across the country such as pharmacies or retailers where people with private health coverage will be able to order online or walk in and pick up at-home over-the-counter COVID-19 tests for free, rather than going through the process of having to submit claims for reimbursement. Consumers can find out from their plan or insurer if it provides direct coverage of over-the-counter COVID-19 tests through such a program or whether they will need to submit a claim for reimbursement. If you are charged for your test after January 15, keep your receipt and submit a claim to your insurance company for reimbursement.
How long can loss of smell from COVID-19 last?
In most cases, loss of smell lasts only a few weeks, but for more than 12 percent of people with COVID-19, olfactory dysfunction persists in the form of ongoing reduction in the ability to smell or changes in how smells are perceived.
When will your sense of taste and smell come back after COVID-19 on average?
When these support cells regenerate (on average four to six weeks later; for some it takes longer) your sense of smell will return. Smell and taste are intertwined in our brain, so when you lose your sense of smell, you also lose your sense of taste.
Where can I find a location that has at-home over-the-counter COVID-19 tests?
Consumers can visit stores online or in-person. The Biden-Harris Administration is also strongly incentivizing health plans and insurers to set up a network of convenient options across the country like pharmacies or retailers, including online retailers, where people can get COVID-19 tests for free at the point of sale, rather than having to submit claims for reimbursement. Consumers can find out from their plan or insurer if it is providing direct coverage of over-the-counter COVID-19 tests through such a network of preferred pharmacies or retailers.
Are COVID-19 self-tests reliable?
Positive results from self-tests are highly reliable. Negative results from self-tests do not rule out SARS-CoV-2 infection. A negative self-test result may not be reliable, especially if you have symptoms associated with COVID-19.
What is the difference between a COVID-19 rapid Point-of-Care test and a self-test?
Who is the CEO of Ellume?
Ellume Founder, CEO and Managing Director Dr Sean Parsons spoke with David Koch on Channel 7’s Sunrise program last week to discuss Ellume’s US$231.8 million contract with the U.S. Government to establish a U.S. manufacturing facility and deliver 8.5 million COVID-19 home tests across the U.S in the…
Where is Ellume located?
team to support the company’s rapid growth. Ellume establishes state-of-the-art diagnostic manufacturing facility in Frederick, Maryland, which is on track to begin limited operation in second half 2021; The facility was funded…
What is Ellume Lab?
Ellume is a Health Technology company that develops and manufactures connected real-time diagnostics for doctors and consumers. The Company develops ellume·lab, a versatile and convenient diagnostic device that complements a doctor’s decision making. The device allows for accurate and real-time near-patient testing in the convenience of a doctor’s office.
Ellume’s agreement with the U.S. government could boost its revenue
As part of the contract, Ellume is supplying the U.S. government with 8.5 million of its home tests. This deal is set to boost the company’s revenue. Companies that are helping to address the COVID-19 health crisis have seen a spike in their stocks. Moderna is one example —the stock rallied last year and outperformed the S&P 500 by a wide margin.
Who owns Ellume Health?
Ellume Health has developed digital diagnostics for several diseases. It was founded in 2010 by Dr. Sean Parsons, who is currently the company’s managing director. The company expects to reach a run rate of 19 million COVID-19 tests per month by the end of 2021 at its U.S. facility.
Will Ellume Health IPO?
Not much is known about Ellume Health’s investors or valuation. The company engaged PAC Partners in 2019 for IPO plans. However, there hasn’t been much headway on its listing since then. Paul Darrouzet, one of Ellume’s early investors, holds a quarter of the company.
Is Ellume Health publicly traded?
Ellume Health isn’t publicly traded, which means you can’t buy the stock. However, investors shouldn’t lose heart. The company’s deal with the U.S. government is set to boost its popularity in U.S. markets and its revenue. Given that 2020 was the best year for U.S. IPOs since 1998, it’s possible that Ellume may soon contemplate a U.S. listing.
Is Ellume listed on the ASX?
Ellume isn’t listed on any market, including the ASX (Australian Stock Exchange). If Ellume decides to go public, doing so through a SPAC (special purpose acquisition company) could be a good route. In 2020, SPACs raised almost as much money as traditional IPOs. SPACs are especially popular among loss-making electric vehicle companies.
Publicly traded COVID-19 testing companies
While Ellume Health isn’t publicly traded, Abbott Laboratories, Quest Diagnostics, and Chembio Diagnostics stocks are all public and good plays on the COVID-19 testing theme.